Therefore GPR55 expression appears to vary depending on species, dietary intake and tissue type, and may also be a beneficial therapeutic target for obesity-related comorbidities such as type 2 diabetes mellitus. This evidence concerns the gene GPR55 and obesity due to melanocortin 4 receptor deficiency.